abstract |
The present invention encompasses novel 1,4-dihydro-3,1-benzoxazin-2- one derivatives, which are surprisingly found to be efficacious in animal models of CNS disorders and, as such, are valuable candidates for the prevention or treatment of CNS (Central Nervous System) diseases or disorders. |